Strong outlook for cell and gene therapy market despite technical challenges

and industry collaboration will play a significant role in overcoming these hurdles, ultimately ensuring the successful commercialization of cell and gene therapies. The progress in this sector remains promising, driven by innovation, collaboration, and a commitment to navigating the technical and regulatory challenges ahead. As the CGT market continues to expand rapidly, stakeholders must remain agile and proactive in addressing these challenges to fully realize the potential of these life-changing therapies.